Intestinal Cell New Volume 8.31 | Aug 26 2022

    0
    18








    2022-08-26 | ICN 8.31


    Intestinal Cell News by STEMCELL Technologies
    Vol. 8.31 – 26 August, 2022
    TOP STORY

    Optimized Human Intestinal Organoid Model Reveals Interleukin-22-Dependency of Paneth Cell Formation

    Scientists optimized human small intestinal organoid culturing, constitutively generating all differentiated cell types while maintaining an active stem cell compartment.
    [Cell Stem Cell]

    Full ArticleGraphical Abstract

    ON987CXN-sep-728x90-2022
    PUBLICATIONSRanked by the impact factor of the journal

    Inflammation Triggers ILC3 Patrolling of the Intestinal Barrier

    Using intravital imaging, researchers observed that villus group 3 innate lymphoid cells were largely immotile at steady state but acquired migratory ‘patrolling’ attributes and enhanced cytokine expression in response to inflammation.
    [Nature Immunology]

    Full Article

    CK2-Induced Cooperation of HHEX with the YAP-TEAD4 Complex Promotes Colorectal Tumorigenesis

    Hematopoietically expressed homeobox (HHEX) was required for the pro-tumorigenic effects of yes-associated protein (YAP) during colorectal cancer progression. In response to serum stimulation, Casein Kinase 2 (CK2) phosphorylated HHEX and enhanced its interaction with TEAD4.
    [Nature Communications]

    Full Article

    Transposon-Activated POU5F1B Promotes Colorectal Cancer Growth and Metastasis

    Scientists found that expression of the hominid-restricted retrogene POU5F1B through aberrant activation of a primate-specific endogenous retroviral promoter was a strong negative prognostic biomarker and demonstrated that POU5F1B fostered the proliferation and metastatic potential of colorectal cancer cells.
    [Nature Communications]

    Full Article

    CEP63 Upregulates YAP1 to Promote Colorectal Cancer Progression through Stabilizing RNA Binding Protein FXR1

    The authors demonstrated that centrosomal protein 63 (CEP63) protein was upregulated in a large cohort of colorectal cancer tissues and predicted poor prognosis, and USP36 was identified for stabilizing CEP63 by enhancing its K48-dependent deubiquitination.
    [Oncogene]

    Abstract

    Combinatorial Treatment with Statins and Niclosamide Prevents CRC Dissemination by Unhinging the MACC1-β-Catenin-S100A4 Axis of Metastasis

    Metastasis-associated in colorectal cancer-1 (MACC1) strengthened the interaction of β-catenin with TCF4, thus inducing S100A4 synthesis transcriptionally, resulting in elevated secretion to enforce cell motility and metastasis.
    [Oncogene]

    Full Article

    Efficacy of SCF Drug Conjugate Targeting C-KIT in Gastrointestinal Stromal Tumor

    Investigators produced a stem cell factor (SCF)-emtansine drug conjugate with favorable drug efficacy towards gastrointestinal stromal tumor cells and evaluated it using in vitro cell-based assays and an in vivo xenograft mouse model.
    [BMC Medicine]

    Full Article

    CDK5RAP3 Acts as a Tumor Suppressor in Gastric Cancer through the Infiltration and Polarization of Tumor-Associated Macrophages

    The absence of CDK5RAP3 in gastric cancer cells allowed macrophages to secrete more matrix metalloproteinase 2 to promote the epithelial-mesenchymal transition process of gastric cancer cells, thereby enhancing the invasion and migration ability.
    [Cancer Gene Therapy]

    Full Article

    CHK2 Activation Contributes to the Development of Oxaliplatin Resistance in Colorectal Cancer

    A proteomic screen was performed to reveal altered protein kinase phosphorylation in oxaliplatin-resistant colorectal cancer (CRC) tumor spheroids. The function of CHK2 was characterised using several biochemical techniques and evident using in vitro cell and in vivo tumor models.
    [British Journal of Cancer]

    Full Article

    Jejunum-Derived NF-κB Reporter Organoids as 3D Models for the Study of TNF-Alpha-Induced Inflammation

    Scientists established, characterized, and validated 3D cultures of intestinal organoids obtained from biopsies of NF-κB-RE-Luc mice.
    [Scientific Reports]

    Full Article

    An ISSCR 2022 COREdinates Webinar: Differentiation of High-Quality hPSCs Using STEMdiff â„¢ and TeSR â„¢-AOF, presented by Kim Snyder. Click to Watch Now.
    REVIEWS

    Fructose 1-Phosphate, an Evolutionary Signaling Molecule of Abundancy

    Recent experimental studies have shown that fructose not only serves as a substrate for, among others, intrahepatic lipid formation, but also has a signaling function.
    [Trends in Endocrinology and Metabolism]

    Abstract

    INDUSTRY AND POLICY NEWS

    Anthos Therapeutics Launches Second Phase III Clinical Trial of Its Dual-Acting Factor XI Inhibitor, Abelacimab

    Anthos Therapeutics announced the initiation of recruitment for its second Phase III clinical trial investigating abelacimab, its novel dual-acting fully human monoclonal antibody targeting both Factor XI and Factor XIa.
    [Anthos Therapeutics]

    Press Release

    FEATURED EVENT

    5th International Cancer Symposium

    November 2 – 4, 2022
    Lyon, France

    > See All Events

    JOB OPPORTUNITIES

    Senior Researcher – Intestinal Microbiology

    Technical University of Denmark – Lyngby, Denmark

    Associate Professor – Solid Cancer Tumor Development

    Michigan State University – East Lansing, Michigan, United States

    Postdoctoral Researcher – Stem Cell and Cancer Biology

    University of California Santa Cruz – Santa Cruz, California, United States

    Postdoctoral Scholar – Host Microbial Interactions and Gastrointestinal COVID-19

    Washington University in St. Louis – St. Louis, Missouri, United States

    Research Associates – Center for Perioperative Organ Protection

    Duke University – Durham, North Carolina, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Intestinal Cell News Twitter